Human resources for health care delivery in Tanzania: a multifaceted problem (Publications)
ABSTRACT: BACKGROUND: Recent years have seen an unprecedented increase in funds for procurement of health commodities in developing countries. A major challenge now is the efficient delivery of commod
Efficacy and safety of artemether-lumefantrine in the treatment of acute, uncomplicated <em>Plasmodium falciparum </em>malaria: a pooled analysis (Publications)
Abstract. Randomized trials have confirmed the efficacy and safety of artemether-lumefantrine (AL) for treatment of uncomplicated Plasmodium falciparum malaria. Data from seven studies supported by No
Diagnostic genotyping of old and new world <em>Leishmania</em> species by PCR-RFLP (Publications)
We have designed a new genotyping scheme for molecular diagnosis of the different Leishmania species pathogenic to humans. This scheme is based on PCR amplified sequences from the gene for the spliced
Towards empirical description of malaria seasonality in southern Africa: the example of Zimbabwe (Publications)
BACKGROUND: Quantitative description and mapping of malaria seasonality is important for timely spatial targeting of interventions and for modelling malaria risk. There is a need for seasonality model
<em>Trichinella spiralis</em>: immunization of pigs with newborn larval antigens (Publications)
The potential of crude Trichinella spiralis newborn larval antigens for pig immunization was investigated. A preparation of whole newborn larvae killed by freezing and thawing, and combined with Freun
Combination of single nucleotide polymorphism and variable-number tandem repeats for genotyping a homogenous population of <em>Mycobacterium... (Publications)
The standard 15- and 24-locus variable-number tandem repeat (VNTR) genotyping methods have demonstrated adequate discriminatory power and a small homoplasy effect for tracing tuberculosis (TB) transmi
Optimization of purine-nitrile TbcatB inhibitors for use in vivo and evaluation of efficacy in murine models (Publications)
There are currently only four clinical drugs available for treating human African trypanosomiasis (HAT), three of which were developed over 60years ago. Despite years of effort, there has been relativ